Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Hypertrophic Cardiomyopathy (HCM) Clinical Trials

8 recruiting trials for Hypertrophic Cardiomyopathy (HCM). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
8
Total Trials
8
Recruiting Now
0
Phase 3 Trials
8
Sponsors

Recruiting Trials

RECRUITINGNCT07344480

Retrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM)

RASopathy-associated hypertrophic cardiomyopathy (RAS-CM) is a disease with high morbidity and high mortality if presenting during infancy. Targeted therapies have shown...

Sponsor: Deutsches Herzzentrum MuenchenEnrolling: 1001 location
RECRUITINGNCT07054073

HCMR Re-Imaging Study

This study aims to learn what might predict heart problems (like sudden death from a fast heart rhythm or heart failure) in people with a genetic condition called hypertrophic...

Sponsor: Christopher KramerEnrolling: 3148 locations
RECRUITINGNCT07354646

The Application of T1 Mapping in Real-World

The goal of this observational study is to create a comprehensive real-world spectrum of T1 mapping measurements across different heart conditions. We aim to establish reference...

Sponsor: Chinese Academy of Medical Sciences, Fuwai HospitalEnrolling: 20001 location
RECRUITINGNCT07263204

AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy

By harnessing artificial intelligence to decode the 12-lead electrocardiogram, the project will enable precise ECG-based phenotyping of hypertrophic cardiomyopathy-accurately...

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEnrolling: 150001 location
RECRUITINGNCT06607471

Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients...

Non-ischemic cardiomyopathies (NICM) represent a heterogeneous group of pathologies characterized by absence of obstructive disease of the epicardial coronary vessels and distinct...

Sponsor: Scientific Institute San RaffaeleEnrolling: 150001 location
RECRUITINGPhase 1 / Phase 2NCT07464132

Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

The purpose of this study is to conduct clinical research on \[68Ga\] Ga-NI-FAPI-04 PET/CT imaging and further investigate its diagnostic value in fibroblast activation related...

Sponsor: Peking Union Medical College HospitalEnrolling: 301 location
RECRUITINGNCT07359690

Multimodal Analysis of Endomyocardial Biopsies

The goal of this observational study is to pursue a multimodal approach to identify the molecular signatures and immune signalling molecules of various myocardial diseases and...

Sponsor: University Hospital, EssenEnrolling: 2161 location
RECRUITINGNCT06813443

Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

The study aims to identify new diagnostic and prognostic markers for CMP that can help predict disease progression. In particular, the study will focus on microRNAs (miRNAs) and...

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di BolognaEnrolling: 7003 locations